693JJ923R000113: Collegiate Impaired Driving Learning Collaborative (CIDLC)
Closed
This grant is closed. A newer notice from the same program is open now: State Process for Informing Consumers of Recalls Program (NHTSA-693JJ927R000007-FY27). Status: Closes February 4, 2027 (89 days left). It is in our archive of National Highway Traffic Safety Administration notices from 2023.
National Highway Traffic Safety Administration offered grants of up to $750,000 to any type of organization. It expected to make one award. Applications closed on May 15, 2023.
From the official notice on Grants.gov, last changed March 14, 2023. Checked November 7, 2026.
- Award ceiling$750,000
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 14, 2023 |
|---|---|
| Deadline | May 15, 2023 |
| Archived by Grants.gov | June 14, 2023 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past National Highway Traffic Safety Administration (NHTSA) Discretionary Safety Grants and Cooperative Agreements awards averaged $1.8 million; this notice allows up to $750,000 per award.
- Most of the program's money (59% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
PURPOSE AND OBJECTIVE This purpose of this Cooperative Agreement (CA or Agreement) is to establish, pilot, and demonstrate the potential of a traffic safety related Learning Collaborative model, where multiple parties support each other toward a shared goal using a proven framework and process, to develop and refine a program to prevent impaired driving among 18–24-year-olds. The Recipient will establish a Collegiate Impaired Driving Learning Collaborative (CIDLC) that will plan, develop, study, and implement a scalable program to promote impaired driving prevention on college and university campuses. The goals of this Cooperative Agreement are to: (1) establish and manage a small group of college and university representatives; (2) facilitate the measurement and understanding of the impaired driving problem on and around college campuses as well as what is being done to combat it; (3) develop, plan and test impaired driving prevention methods, adjusting as needed based on outcomes; (4) develop an effective program based on what is learned; (5) disseminate the results to other schools and stakeholders in a format that is easy to use and replicate; and (5) produce a report evaluating the program, publishing the results and providing a model to establish the program at colleges and universities. FUNDING AND TYPE OF AWARD A total of up to $750,000.00 is available to fund up to one (1) discretionary Cooperative Agreement and is subject to the availability of funds. NHTSA will only accept one (1) application from each eligible applicant (see Section C.1, Eligible Applicants). Submission of an application is not a guarantee of award. Submission of an application is not a guarantee of award. The Government’s obligations under this Cooperative Agreement are contingent upon the availability of appropriated funds from which payment for Cooperative Agreement purposes can be made. No legal liability on the part of the Government for any payment may arise until funds are made available.
Who has won National Highway Traffic Safety Administration (NHTSA) Discretionary Safety Grants and Cooperative Agreements grants before
From fiscal 2021 to 2025, National Highway Traffic Safety Administration (NHTSA) Discretionary Safety Grants and Cooperative Agreements (20.614) awarded $353 million across 195 grant awards, an average of $1.8 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Highway Patrol, California | California | 3 | $64.4 million |
| Automotive Coalition for Traffic Safety, Inc. | Virginia | 2 | $61.5 million |
| Governors Highway Safety Association (Ghsa) | District of Columbia | 3 | $16.6 million |
| Maryland Department of Transportation | Maryland | 1 | $13.2 million |
| Oregon Department of Transportation | Oregon | 1 | $12.2 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, NHTSA-693JJ927R000007-FY27, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 693JJ923R000113 still open?
No. It closed on May 15, 2023. A newer notice is open: NHTSA-693JJ927R000007-FY27, closes February 4, 2027 (89 days left).
Who can apply for Collegiate Impaired Driving Learning Collaborative (CIDLC)?
National Highway Traffic Safety Administration accepted applications from any type of organization.
What is the deadline for Collegiate Impaired Driving Learning Collaborative (CIDLC)?
Closed May 15, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $750,000 each.
Who has won National Highway Traffic Safety Administration (NHTSA) Discretionary Safety Grants and Cooperative Agreements grants before?
The largest recipients over five fiscal years were Highway Patrol, California, Automotive Coalition for Traffic Safety, Inc., Governors Highway Safety Association (Ghsa). The program made 195 awards worth $353 million in that time.
Similar open grants
- Impact Aid Discretionary Construction Grant Program - 84.041C
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)